< Back to latest news & events

News

LSPN Europe 2023

August 2023

Event date: 21st November 2023

HGF are gold sponsors of LSPN Europe which is due to go ahead at BMA House, Tavistock Square in London on 21st November.

This event will explore some of the latest challenges in protecting innovation in the pharmaceutical and biotechnology industry right now and offer insights from leading experts on how to overcome them.

HGF Partner & IP Solicitor , Michelle Davies is hosting the roundtable discussion group ‘Post-pandemic licensing and collaboration’ at the event.

Partner & Patent Attorney Dr (Jonquil) Claire Irvine will also be hosting the insightful round table ‘The divergent CRISPR patent licensing landscape in Europe and the US.’

Patent Attorney Jade Cheng, Marta Kanabus & Roxna Kapadia , Partners Rachel Fetches and Andrew Wells are also attending the event.

FIND OUT MORE

Latest updates

PRESS RELEASE - HGF secures private equity investment.

HGF secures private equity investment to propel its vision of being Europe’s IP Firm of Choice; to  attract top talent and to deliver excellence to clients. Over the past 30 …

Read article

Managing IP Rising Stars 2024

We are delighted to announce that 12 of our esteemed attorneys have been listed in the 2024 Managing Intellectual Property (MIP) Rising Stars guide! This prestigious recognition highlights the best …

Read article
Event - 15th - 16th October 2024

LSPN North America Fall 2024

HGF are proud to be platinum sponsors of LSPN North America Fall 2024. This year’s event will be held in San Francisco on Tuesday 15th and Wednesday 16th of October …

Event details

Agritech Thymes: Exploring the Agritech IP landscape – past trends and future insights

The agrifood patent landscape analysis recently reported by WIPO provides interesting insights into key areas of innovation and the IP strategies being adopted. The agrifood industry, encompassing both agritech and …

Read article

The Patent Lawyer: UPC’s first year: emergence of a purely civil law system?

The UPC passed its milestone 1 year anniversary on 1 June 2024. At the time of writing we are still awaiting the first substantive decisions on invalidity and infringement, there …

Read article

NK Cell Therapy – an IP update

Advances in CAR-T cell therapy have carved a path for improved treatments in the field of oncology, in particular haematological cancers. In 2018, the European Medicine’s Agency approved the first …

Read article
See all updates